Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2601-2606
Published online before print May 5, 2003, doi: 10.1161/01.CIR.0000066910.02844.D0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/20/2601    most recent
01.CIR.0000066910.02844.D0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Day, S. M.
Right arrow Articles by Fay, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Day, S. M.
Right arrow Articles by Fay, W. P.
Related Collections
Right arrow Arterial thrombosis
Right arrow Oxidant stress
Right arrow Animal models of human disease

(Circulation. 2003;107:2601.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis

Sharlene M. Day, MD; Damon Duquaine, BS; Lakshmi V. Mundada, MS; Rekha G. Menon, MD; Bobby V. Khan, MD, PhD; Sanjay Rajagopalan, MD; William P. Fay, MD

From the University of Michigan Medical School, Division of Cardiology, Ann Arbor (S.M.D., D.D., L.V.M., S.R., W.P.F.); and Emory University School of Medicine, Division of Cardiology, Atlanta, Ga (R.G.M., B.V.K.).

Correspondence to Sharlene M. Day, MD, University of Michigan Medical Center, 7301 MSRB III, 1150 W Medical Center Dr, Ann Arbor, MI 48109-0644. E-mail sday{at}umich.edu

Background— Iron overload has been implicated in the pathogenesis of ischemic cardiovascular events. However, the effects of iron excess on vascular function and the thrombotic response to vascular injury are not well understood.

Methods and Results— We examined the effects of chronic iron dextran administration (15 mg over 6 weeks) on thrombosis, systemic and vascular oxidative stress, and endothelium-dependent vascular reactivity in mice. Thrombus generation after photochemical carotid artery injury was accelerated in iron-loaded mice (mean time to occlusive thrombosis, 20.4±8.5 minutes; n=10) compared with control mice (54.5±35.5 minutes, n=10, P=0.009). Iron loading had no effect on plasma clotting, vessel wall tissue factor activity, or ADP-induced platelet aggregation. Acute administration of DL-cysteine, a reactive oxygen species scavenger, completely abrogated the effects of iron loading on thrombus formation, suggesting that iron accelerated thrombosis through a pro-oxidant mechanism. Iron loading enhanced both systemic and vascular reactive oxygen species production. Endothelium-dependent vasorelaxation was impaired in iron-loaded mice, indicating reduced NO bioavailability.

Conclusions— Moderate iron loading markedly accelerates thrombus formation after arterial injury, increases vascular oxidative stress, and impairs vasoreactivity. Iron-induced vascular dysfunction may contribute to the increased incidence of ischemic cardiovascular events that have been associated with chronic iron overload.


Key Words: thrombosis • free radicals • arteries




This article has been cited by other articles:


Home page
Diabetes CareHome page
S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah
The Role of Iron in Diabetes and Its Complications
Diabetes Care, July 1, 2007; 30(7): 1926 - 1933.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. N Hanson, H. M Engelman, D L. Alekel, K. L Schalinske, M. L Kohut, and M. B Reddy
Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-D. Tang and S. D. Katz
Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options
Circulation, May 23, 2006; 113(20): 2454 - 2461.
[Full Text] [PDF]


Home page
CirculationHome page
D. L. van der A, J. J.M. Marx, D. E. Grobbee, M. H. Kamphuis, N. A. Georgiou, J. H. van Kats-Renaud, W. Breuer, Z. I. Cabantchik, M. Roest, H. A.M. Voorbij, et al.
Non-Transferrin-Bound Iron and Risk of Coronary Heart Disease in Postmenopausal Women
Circulation, April 25, 2006; 113(16): 1942 - 1949.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Zheng, R. Cable, B. Spencer, N. Votto, and S. D. Katz
Iron Stores and Vascular Function in Voluntary Blood Donors
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1577 - 1583.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
J. Borawski, J. Gozdzikiewicz, P. Abramowicz, B. Naumnik, and M. Mysliwiec
Endothelial Injury Markers With High-dose IntravenousIron Therapy in Renal Failure
Clinical and Applied Thrombosis/Hemostasis, October 1, 2004; 10(4): 403 - 406.
[Abstract] [PDF]


Home page
Vasc MedHome page
G. Ramakrishna, T. W Rooke, and L. T Cooper
Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Vascular Medicine, August 1, 2003; 8(3): 203 - 210.
[Abstract] [PDF]